CTRI/2017/10/010032招募中2 期
An Open Label Single Arm Clinical Study on the Effect of Vasa Khanda Kushmanda Avaleha in Amlapitta
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Diagnosis will be made on the basis of signs and symptoms of Amlapitta viz. Avipaka(indigestion), Klama, Utklesha, Tikta Amla Udgara(sour belching), Gaurava(heaviness), Hrit Kanta Daha(burning sensation in epigastric region and throat) and Aruchi(tastelessness)
- •Inclusion criteria include patients of age between 20 and 60 years of either gender.
- •Patients with chronicity less than 5 years.
- •Patients who are ready to participate and sign the informed consent form.
排除标准
- •Exclusion criteria are as follows.
- •Patients with history of systemic illness like diabetis mellitus and hypertension, hypothyroidism, cardiac pathology, immunodeficiency disorders like AIDS and Arbuda
- •Patients with history of Parinama Shula (gastric ulcer, duodenal ulcer), Annadrava Shula, Krimiroga
- •Patient with history of haematemesis, maleana and anaemia
- •Patients with drug- induced Amlapitta
- •Patients with history of alcohol and tobacco- induced Amlapitta
- •Pregnant ladies
研究者
相似试验
尚未招募
不适用
Effect of Marmani Vati Lepa in IV cannula site swellingCTRI/2022/03/040773Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
招募中
2 期
A Clinical Study on Combined Effectiveness of Oral and Topical Application of an Ayurvedic Medicine - Agastya Ghrita in the Management of Retinitis PigmentosaCTRI/2017/05/008552Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital30
尚未招募
Unknown
Effect of Chaturbeeja choorna in the management of primary dysmenorrhoea i.e., painful menstruation.CTRI/2024/02/062406Dr Anushree A B C
进行中(未招募)
1 期
A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis.EUCTR2015-003797-32-ESAbbVie Deutschland GmbH & Co. KG160
进行中(未招募)
1 期
A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis.EUCTR2015-003797-32-BEAbbVie Deutschland GmbH & Co. KG175
